Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein and lipid deposits on contact lens surfaces refer to the accumulation of tear film components, such as lysozyme, lactoferrin, albumin, and various lipids (e.g., cholesterol and wax esters), onto the polymer matrix of contact lenses. This phenomenon is a primary challenge in optometry as it leads to reduced visual clarity, physical discomfort, and increased risk of inflammatory or infectious complications like giant papillary conjunctivitis and microbial keratitis. While not a single therapeutic target in the traditional pharmacological sense, these deposits are the primary focus of ophthalmic lens care solutions and surface modification technologies. Effective management involves the use of surfactants, chelating agents, and enzymes to maintain lens hydrophobicity and prevent the denaturation of proteins, which can otherwise trigger immune responses in the ocular environment.
Cleaning agents and multipurpose solutions act via surfactant-mediated emulsification of lipids, proteolytic digestion of proteins, or oxidative denaturation to remove deposits from the lens matrix and surface.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein and lipid deposits on contact lens surfaces.